We're joined today by James Maitland, a leading expert in medical robotics and IoT applications, whose work focuses on integrating advanced technology safely and effectively into healthcare. With the explosion of generative AI, the healthcare sector faces a dual reality: unprecedented opportunity
A Regulatory Standoff with High Stakes In a move that sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) has taken the extraordinary step of refusing to conduct a formal review of Moderna's biologics license application for its mRNA-based influenza
In a surprising display of resilience, the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) not only maintained its operational tempo but also increased its authorization of novel medical devices in 2025, a period marked by significant staff reductions under the
A Federal Reckoning: Targeting the Middlemen of Medicine The persistent and escalating cost of prescription drugs in the United States has ignited widespread public frustration and become a recurring battleground in political debate. A proposed rule from the Department of Labor (DOL) is now taking
Patient Safety in Question Unpacking the Integra Wound Care Recall When a medical device intended to heal instead causes harm, it strikes at the core of patient trust, demanding an immediate and thorough investigation into what went wrong. Medical device company Integra LifeSciences has initiated a
The intricate web connecting pharmaceutical manufacturers to patient medicine cabinets is quietly being rewoven as a landmark settlement threatens to expose the secretive financial mechanics driving America's insulin crisis. For years, the rising cost of this life-saving medication has been a
